SBC — SBC Medical group Cashflow Statement
0.000.00%
Last trade - 00:00- $326.19m
- $220.21m
- $173.61m
Annual cashflow statement for SBC Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 5.55 | 38.6 | 46.7 | 51 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 2.96 | 3.4 | 31.4 | -7.85 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -10.6 | -7.65 | -46.9 | -26.5 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.047 | 50.7 | 20.6 | 24.7 |
| Capital Expenditures | -24.9 | -11.2 | -3.41 | -2.37 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -7.71 | 13 | -6.69 | -18.6 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -32.7 | 1.79 | -10.1 | -21 |
| Financing Cash Flow Items | -2.89 | 2.56 | 11 | 10.2 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -7.98 | 6.14 | 23 | 38.3 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -52.8 | 51.3 | 22 | 38.7 |